From wellness to medicine: Geroscience, biomarkers and the translational emergence of longevity medicine
- 1School of Neuroscience, King's College London, London, UK
- 2Cutrale Perioperative and Ageing Group, Department of Bioengineering, Imperial College London, London, UK
Abstract
Longevity medicine has emerged at the intersection of geroscience, biomarker science and preventive healthcare, yet its origins and relationship to conventional medicine remain incompletely understood. This article examines how advances in ageing biology transformed ageing from an inevitable consequence of life into a measurable and potentially modifiable determinant of health. Historically, medicine has focused on the diagnosis and treatment of established disease, limiting its ability to address gradual biological decline before pathology develops. Geroscience challenged this paradigm by identifying shared biological mechanisms that contribute to ageing and multiple chronic diseases, while advances in biomarker science enabled ageing-related processes to be quantified in living humans. However, the ability to measure ageing biology developed more rapidly than the clinical frameworks required to act upon it. We argue that the emergence of longevity-focused services outside traditional healthcare systems represents a pre-institutional translational phase in the evolution of longevity medicine. The integration of ageing biology into clinical practice will require new clinical, regulatory and educational frameworks to support healthspan-focused preventive care.
Related
- Lifestyle-Associated Biomarkers of Cellular and Whole-Organism Aging: A Practical Roadmap for Human Geroscience Trials
- Converging Paths: Artificial Intelligence for Integrating Biological and Digital Biomarkers in Personalized Longevity Medicine
- EEG in Parkinson’s Disease: Mechanisms, Biomarkers and Translational Opportunities
- The Gut Virome in Gastrointestinal Cancers: Mechanisms, Biomarkers, and Translational Opportunities.
- Is Aging a Failure to Resolve? Integrating Damage Responses, Regenerative Decline, and Geroscience Interventions
BibTeX
@article{fasel2026from,
title = {{From wellness to medicine: Geroscience, biomarkers and the translational emergence of longevity medicine}},
author = {Chloé A. Fasel and Louis J. Koizia and Benjamin H.L. Harris},
journal = {Future Healthcare Journal},
year = {2026},
month = nov,
doi = {10.1016/j.fhj.2026.100564},
url = {https://doi.org/10.1016/j.fhj.2026.100564},
note = {CC BY},
}
RIS
TY - JOUR
TI - From wellness to medicine: Geroscience, biomarkers and the translational emergence of longevity medicine
AU - Chloé A. Fasel
AU - Louis J. Koizia
AU - Benjamin H.L. Harris
PY - 2026
DA - 2026/11/03
JO - Future Healthcare Journal
DO - 10.1016/j.fhj.2026.100564
UR - https://doi.org/10.1016/j.fhj.2026.100564
AB - Longevity medicine has emerged at the intersection of geroscience, biomarker science and preventive healthcare, yet its origins and relationship to conventional medicine remain incompletely understood. This article examines how advances in ageing biology transformed ageing from an inevitable consequence of life into a measurable and potentially modifiable determinant of health. Historically, medicine has focused on the diagnosis and treatment of established disease, limiting its ability to address gradual biological decline before pathology develops. Geroscience challenged this paradigm by identifying shared biological mechanisms that contribute to ageing and multiple chronic diseases, while advances in biomarker science enabled ageing-related processes to be quantified in living humans. However, the ability to measure ageing biology developed more rapidly than the clinical frameworks required to act upon it. We argue that the emergence of longevity-focused services outside traditional healthcare systems represents a pre-institutional translational phase in the evolution of longevity medicine. The integration of ageing biology into clinical practice will require new clinical, regulatory and educational frameworks to support healthspan-focused preventive care.
SN - 2514-6645
SN - 2514-6653
ER -